about
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach t...
Read More
23.5M
XNAS Volume
High vol. this week
XNAS 19 May, 2025 5:30 PM (EDT)
Board Meeting
The board meeting for Affimed N.V. is scheduled for today, for the purpose of Affimed NV Annual Report for 2024
See details
Not Eligible
Expensive Valuation
Technically Bearish
Affimed N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..